Board Change • Jun 04
Less than half of directors are independent Following Director Dan Rogers' arrival on 01 June 2026, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Brian Atwood was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jun 03
Launch One Acquisition Corp. Announces Board and Committee Changes Launch One Acquisition Corp. announced that on June 2, 2026, the board of directors appointed Daniel Clifford Rogers as a member of the Board. Mr. Rogers was appointed as a replacement for Dr. Risa Stack, who resigned from the Board and as chairperson of the audit committee of the Board, and as a member of the compensation committee of the Board, effective as of the same date. The Board appointed Mr. Rogers as chair of the Audit Committee to fill the vacancy created by Ms. Stack's resignation. Mr. Rogers will serve as a member of the second class of directors, which term will expire at the Company's first annual general meeting. Daniel Clifford Rogers, age 56, serves as a consulting Chief Financial Officer focused on long-term and interim engagements with financial technology, fintech, financial services, and SaaS companies. Dan served as Chief Financial Officer of Newcourt Acquisition Corp. from March 2021 to June 2023 and Chief Financial Officer of Papaya Growth from November 2021 to March 2025. From October 2019 to October 2024, Mr. Rogers served as Founder and Chief Executive Officer of FintechForce, a boutique advisory, accounting, and tax firm serving fintech companies. From March 2020 through March 2023, he also served as Chief Financial Officer of Helpshift, an enterprise SaaS company. From 2017 to 2019, Mr. Rogers served as Chief Financial Officer of Endpoint Clinical. Earlier in his career, from 1988 to 2007, Mr. Rogers served as Vice President at Wells Fargo. Mr. Rogers received a Bachelor of Science from Lafayette College in 1992 and an MBA from Pennsylvania State University in 1998. Announcement • Jun 25
Minovia Therapeutics LTD entered into a Business Combination Agreement to acquire Launch One Acquisition Corp. (NasdaqGM:LPAA) in a reverse merger transaction for approximately $240 million. Minovia Therapeutics LTD entered into a Business Combination Agreement to acquire Launch One Acquisition Corp. (NasdaqGM:LPAA) in a reverse merger transaction for approximately $240 million on June 25, 2025. Upon closing of the transaction, the combined entity will operate under the name Mito US One Ltd. and is expected to be listed on Nasdaq. The consideration consists of ordinary shares worth $180 million plus the amount of any financing made directly into the Company prior to the Closing and the Company equity holders will be eligible after the closing of the Business Combination to potentially receive shares worth $57.5 million in the aggregate as an earnout if a certain share price target or development milestone is met. The boards of directors of both Minovia and Launch One have unanimously approved the transaction. The transaction is subject to customary closing conditions and shareholder approvals. The transaction is expected to close in the fourth quarter of 2025. Bevilacqua PLLC is acting as legal advisor to Minovia. Ellenoff Grossman & Schole LLP is acted as legal advisor to Launch One. 
